Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer

Integrins are transmembrane glycoprotein receptors that regulate cell-matrix interactions, thus functioning as sensors from the environment. They also act as cell adhesion molecules that are responsible for the maintenance of the normal epithelial phenotype. Some studies have reported a correlation between carcinogenesis and changes in integrin expression, especially β1 integrin, however its role in prostate cancer (PC) is unclear. The aim of our study was to evaluate the expression of β1 integrin in localized PC and to correlate the pattern of expression with recurrence after surgical treatment. Methods For this case-control study, we retrospectively selected surgical specimens from 111 patients with localized PC who underwent radical prostatectomy. Recurrence was defined as a PSA level exceeding 0.2ng/mL after surgery, and the median follow-up was 123 months. Integrin expression was evaluated by immunohistochemistry in a tissue microarray containing two samples from each tumor. We employed a semiquantitative analysis and considered a case as positive when the expression was strong and diffusely present. Results: There was a loss of 11 cases during the tissue micro array assembling. β1 expression was positive in 79 of the 100 evaluated cases (79%). The univariate and multivariate analyses showed that the negative expression of β1 integrin was associated with biochemical recurrence (p = 0.047) and time to recurrence after radical prostatectomy (p = 0.023). When β1 was negative, the odds ratio for recurrence was 2.78 times higher than that observed in the positive cases [OR = 2.78, p = 0.047, IC 95% (1.01-7.66)]. Conclusions: The loss of β1 integrin immune expression was correlated with biochemical recurrence in patients treated with radical prostatectomy for localized PC.

Saved in:
Bibliographic Details
Main Authors: Pontes-Junior,Jose, Reis,Sabrina Thalita, Bernardes,Felipe S., Oliveira,Luiz C. N., Barros,Erika Aparecida Felix de, Dall'oglio,Marcos Francisco, Timosczuk,Luciana M. S., Ribeiro-Filho,Leopoldo A., Srougi,Miguel, Leite,Katia R. M.
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Urologia 2013
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000300335
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1677-55382013000300335
record_format ojs
spelling oai:scielo:S1677-553820130003003352013-08-16Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancerPontes-Junior,JoseReis,Sabrina ThalitaBernardes,Felipe S.Oliveira,Luiz C. N.Barros,Erika Aparecida Felix deDall'oglio,Marcos FranciscoTimosczuk,Luciana M. S.Ribeiro-Filho,Leopoldo A.Srougi,MiguelLeite,Katia R. M. Prostatic Neoplasms Cell Adhesion Molecules Prognosis Integrins Integrins are transmembrane glycoprotein receptors that regulate cell-matrix interactions, thus functioning as sensors from the environment. They also act as cell adhesion molecules that are responsible for the maintenance of the normal epithelial phenotype. Some studies have reported a correlation between carcinogenesis and changes in integrin expression, especially β1 integrin, however its role in prostate cancer (PC) is unclear. The aim of our study was to evaluate the expression of β1 integrin in localized PC and to correlate the pattern of expression with recurrence after surgical treatment. Methods For this case-control study, we retrospectively selected surgical specimens from 111 patients with localized PC who underwent radical prostatectomy. Recurrence was defined as a PSA level exceeding 0.2ng/mL after surgery, and the median follow-up was 123 months. Integrin expression was evaluated by immunohistochemistry in a tissue microarray containing two samples from each tumor. We employed a semiquantitative analysis and considered a case as positive when the expression was strong and diffusely present. Results: There was a loss of 11 cases during the tissue micro array assembling. β1 expression was positive in 79 of the 100 evaluated cases (79%). The univariate and multivariate analyses showed that the negative expression of β1 integrin was associated with biochemical recurrence (p = 0.047) and time to recurrence after radical prostatectomy (p = 0.023). When β1 was negative, the odds ratio for recurrence was 2.78 times higher than that observed in the positive cases [OR = 2.78, p = 0.047, IC 95% (1.01-7.66)]. Conclusions: The loss of β1 integrin immune expression was correlated with biochemical recurrence in patients treated with radical prostatectomy for localized PC.info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.39 n.3 20132013-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000300335en10.1590/S1677-5538.IBJU.2013.03.06
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Pontes-Junior,Jose
Reis,Sabrina Thalita
Bernardes,Felipe S.
Oliveira,Luiz C. N.
Barros,Erika Aparecida Felix de
Dall'oglio,Marcos Francisco
Timosczuk,Luciana M. S.
Ribeiro-Filho,Leopoldo A.
Srougi,Miguel
Leite,Katia R. M.
spellingShingle Pontes-Junior,Jose
Reis,Sabrina Thalita
Bernardes,Felipe S.
Oliveira,Luiz C. N.
Barros,Erika Aparecida Felix de
Dall'oglio,Marcos Francisco
Timosczuk,Luciana M. S.
Ribeiro-Filho,Leopoldo A.
Srougi,Miguel
Leite,Katia R. M.
Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer
author_facet Pontes-Junior,Jose
Reis,Sabrina Thalita
Bernardes,Felipe S.
Oliveira,Luiz C. N.
Barros,Erika Aparecida Felix de
Dall'oglio,Marcos Francisco
Timosczuk,Luciana M. S.
Ribeiro-Filho,Leopoldo A.
Srougi,Miguel
Leite,Katia R. M.
author_sort Pontes-Junior,Jose
title Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer
title_short Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer
title_full Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer
title_fullStr Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer
title_full_unstemmed Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer
title_sort correlation between beta1 integrin expression and prognosis in clinically localized prostate cancer
description Integrins are transmembrane glycoprotein receptors that regulate cell-matrix interactions, thus functioning as sensors from the environment. They also act as cell adhesion molecules that are responsible for the maintenance of the normal epithelial phenotype. Some studies have reported a correlation between carcinogenesis and changes in integrin expression, especially β1 integrin, however its role in prostate cancer (PC) is unclear. The aim of our study was to evaluate the expression of β1 integrin in localized PC and to correlate the pattern of expression with recurrence after surgical treatment. Methods For this case-control study, we retrospectively selected surgical specimens from 111 patients with localized PC who underwent radical prostatectomy. Recurrence was defined as a PSA level exceeding 0.2ng/mL after surgery, and the median follow-up was 123 months. Integrin expression was evaluated by immunohistochemistry in a tissue microarray containing two samples from each tumor. We employed a semiquantitative analysis and considered a case as positive when the expression was strong and diffusely present. Results: There was a loss of 11 cases during the tissue micro array assembling. β1 expression was positive in 79 of the 100 evaluated cases (79%). The univariate and multivariate analyses showed that the negative expression of β1 integrin was associated with biochemical recurrence (p = 0.047) and time to recurrence after radical prostatectomy (p = 0.023). When β1 was negative, the odds ratio for recurrence was 2.78 times higher than that observed in the positive cases [OR = 2.78, p = 0.047, IC 95% (1.01-7.66)]. Conclusions: The loss of β1 integrin immune expression was correlated with biochemical recurrence in patients treated with radical prostatectomy for localized PC.
publisher Sociedade Brasileira de Urologia
publishDate 2013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000300335
work_keys_str_mv AT pontesjuniorjose correlationbetweenbeta1integrinexpressionandprognosisinclinicallylocalizedprostatecancer
AT reissabrinathalita correlationbetweenbeta1integrinexpressionandprognosisinclinicallylocalizedprostatecancer
AT bernardesfelipes correlationbetweenbeta1integrinexpressionandprognosisinclinicallylocalizedprostatecancer
AT oliveiraluizcn correlationbetweenbeta1integrinexpressionandprognosisinclinicallylocalizedprostatecancer
AT barroserikaaparecidafelixde correlationbetweenbeta1integrinexpressionandprognosisinclinicallylocalizedprostatecancer
AT dallogliomarcosfrancisco correlationbetweenbeta1integrinexpressionandprognosisinclinicallylocalizedprostatecancer
AT timosczuklucianams correlationbetweenbeta1integrinexpressionandprognosisinclinicallylocalizedprostatecancer
AT ribeirofilholeopoldoa correlationbetweenbeta1integrinexpressionandprognosisinclinicallylocalizedprostatecancer
AT srougimiguel correlationbetweenbeta1integrinexpressionandprognosisinclinicallylocalizedprostatecancer
AT leitekatiarm correlationbetweenbeta1integrinexpressionandprognosisinclinicallylocalizedprostatecancer
_version_ 1756428134189629440